Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances
Molecular Biotechnology · 2025-02 · 67 (2) · 410-424
DOI: 10.1007/s12033-024-01064-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biotechnology, online erschienen am 03.02.2024. Verfasst von Eugenio Gallo. Beteiligte Einrichtung: Avance Biologicals, Department of Medicinal Chemistry, 950 Dupont Street, Toronto, ON, M6H 1Z2, Canada. gallo@avancebiologicals.com. Hauptthemen laut MEDLINE: Antibodies, Artificial Intelligence, Big Data, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: RevivAb.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Avance Biologicals, Department of Medicinal Chemistry, 950 Dupont Street, Toronto, ON, M6H 1Z2, Canada. gallo@avancebiologicals.com.
- RevivAb, Department of Protein Engineering, Av. Ipiranga, 6681, Partenon, Porto Alegre, RS, 90619-900, Brazil. gallo@avancebiologicals.com.
Förderung
- RevivAb
Zitieren
APA
Gallo, E. (2025). Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances. Molecular Biotechnology, 67(2), 410-424. https://doi.org/10.1007/s12033-024-01064-2
Vancouver
Gallo E. Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances. Molecular Biotechnology. 2025;67(2):410-424. doi:10.1007/s12033-024-01064-2
BibTeX
@article{Gallo2025,
author = {Gallo, Eugenio},
title = {Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances},
journal = {Molecular Biotechnology},
year = {2025},
volume = {67},
number = {2},
pages = {410--424},
doi = {10.1007/s12033-024-01064-2}
}
EUVIMED